MET (N-Methyl-N-ethyltryptamine)
MET is a short-acting psychedelic tryptamine and the N-methyl-N-ethyl analog of DMT/DET. It sits between DMT and DET in structure and is generally reported to require injection or smoking for full effect. Essentially no formal human research exists; knowledge is anecdotal.
01 Overview
MET (methylethyltryptamine) is an obscure member of the simple tryptamine family, structurally intermediate between DMT and DET. It appears only sporadically on the research-chemical market and has never been the subject of controlled human trials.
Reported experiences resemble a shorter, sometimes lighter DMT-like state. Because there is no pharmacokinetic characterisation, dose figures below are approximate and derived entirely from self-reports.
02 Mechanism
Presumed 5-HT2A receptor agonist like other classical tryptamine psychedelics; no receptor-binding data specific to MET is published.
03 Dosing
| Tier | Dose | Route | Notes |
|---|---|---|---|
| Common (reported) | 15–30 mg | Vaporised | Anecdotal; short, intense onset. |
| Common (reported) | 20–40 mg | Insufflated | Anecdotal. |
04 Effects
| Effect | Magnitude | Evidence | |
|---|---|---|---|
| Short psychedelic stateRapid-onset, relatively brief visual and cognitive alteration compared with longer tryptamines. | moderate | Anecdotal | |
| EuphoriaMood lift reported by some users. | mild-moderate | Anecdotal |
05 Side effects
| Effect | Severity | Frequency | Evidence | Countermeasures |
|---|---|---|---|---|
| Confusion and disorientationRapid, disorienting onset can be overwhelming. | Moderate | Common | Anecdotal | |
| Cardiovascular stimulationPresumed raised heart rate/blood pressure by analogy to related tryptamines. | Moderate | Unknown | Unconfirmed |